Skip to main content
Have a personal or library account? Click to login
Effects of β-blockers on hemorheological parameters in experimental arterial hypertension Cover

Effects of β-blockers on hemorheological parameters in experimental arterial hypertension

Open Access
|Jul 2026

Abstract

Background: Arterial hypertension is a multifactorial disorder involving elevated blood pressure, microcirculatory and hemorheological disturbances, endothelial dysfunction, and oxidative stress, which contribute to increased peripheral resistance and disease progression. In this study, we aimed to evaluate the effects of β-blockers on hemorheological parameters, nitric oxide bioavailability, and oxidative stress in experimental arterial hypertension.

Methods: Experimental hypertension was induced in male Wistar rats using N^G-nitro-L-arginine methyl ester (L-NAME, 40 mg/kg/day). Animals were divided into control, hypertensive, and treatment groups receiving nebivolol, propranolol, metoprolol, or carvedilol. Blood pressure, hemorheological parameters, nitric oxide levels, and total antioxidant activity were evaluated.

Results: L-NAME administration significantly increased arterial pressure, erythrocyte aggregation, and plasma viscosity, accompanied by reduced NO levels and decreased antioxidant capacity (p < 0.01). β-blocker treatment significantly reduced arterial pressure in all groups. Under the present experimental conditions, nebivolol was associated with the greatest improvement in NOx levels, antioxidant activity, and erythrocyte aggregation. However, because equipotent β-blocker dosing was not established, direct comparisons of efficacy among agents should be interpreted cautiously. Carvedilol demonstrated moderate effects, while propranolol and metoprolol showed less improvement in parameters. β-blocker treatment was associated with simultaneous reductions in pulse arterial pressure and erythrocyte aggregation; however, no formal correlation analysis was performed.

Conclusions: Experimental hypertension is associated with disturbances in the microcirculation–hemorheology–oxidative stress axis. β-blockers partially reverse these alterations, with nebivolol being associated with more pronounced improvement under the conditions of the present study, likely related, at least in part, to its nitric oxide-mediated and antioxidant properties.

DOI: https://doi.org/10.2478/rrlm-2026-0024 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 221 - 230
Submitted on: May 5, 2026
Accepted on: Jun 22, 2026
Published on: Jul 11, 2026
In partnership with: Paradigm Publishing Services

© 2026 Nana Kajaia, Maia Mantskava, Luiza Gabunia, George Ormotsadze, Lela Chkitauri, Elene Gogichaishvili, Sophio Kalmakhelidze, Tamar V Sanikidze, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.